[Federal Register Volume 85, Number 145 (Tuesday, July 28, 2020)]
[Notices]
[Page 45444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: R1-2020-16100]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-683]


Bulk Manufacturer of Controlled Substances Application: AMPAC 
Fine Chemicals Virginia, LLC

    Editorial Note: Notice document 2020-16100, which should have 
published Friday, July 24, 2020, did not appear in that issue. We 
are republishing it here in its entirety.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before September 28, 
2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 16, 2020, AMPAC Fine Chemicals Virginia, LLC, 
2820 North Normandy Drive, Petersburg, Virginia 23805-2380, applied to 
be registered as a bulk manufacturer of the following basic class(es) 
of controlled substances:

------------------------------------------------------------------------
         Controlled substance            Drug code        Schedule
------------------------------------------------------------------------
Methylphenidate.......................        1724  II
Levomethorphan........................        9210  II
Levorphanol...........................        9220  II
Morphine..............................        9300  II
Thebaine..............................        9333  II
Noroxymorphone........................        9668  II
Tapentadol............................        9780  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers. No other 
activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. R1-2020-16100 Filed 7-27-20; 8:45 am]
BILLING CODE 1301-00-D